Citadel Advisors’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73M | Buy |
2,355,899
+2,355,834
| +3,624,360% | +$2.73M | ﹤0.01% | 2418 |
|
|
2025
Q1 | $88 | Sell |
65
-401,624
| -100% | -$544K | ﹤0.01% | 5847 |
|
|
2024
Q4 | $5.29M | Buy |
401,689
+366,635
| +1,046% | +$4.83M | ﹤0.01% | 1759 |
|
|
2024
Q3 | $393K | Sell |
35,054
-395,658
| -92% | -$4.44M | ﹤0.01% | 4029 |
|
|
2024
Q2 | $4.63M | Sell |
430,712
-1,271,034
| -75% | -$13.7M | ﹤0.01% | 1744 |
|
|
2024
Q1 | $25.4M | Buy |
1,701,746
+123,232
| +8% | +$1.84M | ﹤0.01% | 784 |
|
|
2023
Q4 | $28.6M | Buy |
1,578,514
+58,436
| +4% | +$1.06M | 0.01% | 698 |
|
|
2023
Q3 | $26.4M | Sell |
1,520,078
-92,829
| -6% | -$1.61M | 0.01% | 674 |
|
|
2023
Q2 | $29.2M | Buy |
1,612,907
+498,079
| +45% | +$9.03M | 0.01% | 633 |
|
|
2023
Q1 | $29.7M | Buy |
1,114,828
+123,707
| +12% | +$3.29M | 0.01% | 665 |
|
|
2022
Q4 | $19.2M | Buy |
991,121
+573,233
| +137% | +$11.1M | ﹤0.01% | 894 |
|
|
2022
Q3 | $8.73M | Sell |
417,888
-965,439
| -70% | -$20.2M | ﹤0.01% | 1383 |
|
|
2022
Q2 | $11.1M | Buy |
1,383,327
+5,819
| +0.4% | +$46.6K | ﹤0.01% | 1200 |
|
|
2022
Q1 | $9.66M | Buy |
1,377,508
+40,382
| +3% | +$283K | ﹤0.01% | 1445 |
|
|
2021
Q4 | $18.1M | Buy |
1,337,126
+8,760
| +0.7% | +$118K | ﹤0.01% | 999 |
|
|
2021
Q3 | $22.4M | Buy |
1,328,366
+129,961
| +11% | +$2.19M | ﹤0.01% | 840 |
|
|
2021
Q2 | $34.9M | Sell |
1,198,405
-23,775
| -2% | -$692K | 0.01% | 659 |
|
|
2021
Q1 | $48.1M | Sell |
1,222,180
-10,078
| -0.8% | -$396K | 0.01% | 487 |
|
|
2020
Q4 | $28M | Buy |
1,232,258
+2,825
| +0.2% | +$64.2K | 0.01% | 686 |
|
|
2020
Q3 | $27.8M | Sell |
1,229,433
-3,347
| -0.3% | -$75.8K | 0.01% | 612 |
|
|
2020
Q2 | $40M | Buy |
+1,232,780
| New | +$40M | 0.01% | 458 |
|